Taken together, we found that several proteins with inflammatory function were decreased in arthritis CSF after infliximab treatment, including proteins with additional neuro-immunomodulatory function such as FGG, CNTN1 and CADM3. The gene discussed is CADM3; the disease is arthritic joint disease.